Literature DB >> 7822792

Split tolerance in spleen chimeras.

J Sprent1, M Hurd, M Schaefer, W Heath.   

Abstract

Transferring small doses of T cells to heavily irradiated F1 mice expressing isolated MHC class I or class II differences invariably leads to rapid death from graft-vs-host disease (GVHD). Paradoxically, GVHD is mild or absent when irradiated F1 mice are reconstituted with large doses of unseparated parental strain spleen cells. This applies when bulk populations of B6 spleen cells are transferred to irradiated class II-different (B6 x bm12)F1 mice or class I-different (B6 x bm1)F1 mice. In this study, we examined whether the donor T cells in long-term spleen chimeras become tolerant to host MHC Ags. On the basis of skin-allograft rejection and induction of GVHD on adoptive transfer, the results show that the donor T cells display strong tolerance to host antigens; this applies to CD4+ cells in class II-different chimeras and to CD8+ cells in class I-different chimeras. In marked contrast to the profound tolerance seen by these in vivo parameters, little or no tolerance is observed in standard in vitro assays. The results illustrate that typical in vitro tests for alloreactivity are an imprecise guide to physiologic tolerance of T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822792

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor V beta genes.

Authors:  H Shirwan; L Barwari; D V Cramer
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.

Authors:  Miwa Morita; Daniel Joyce; Charles Miller; John J Fung; Lina Lu; Shiguang Qian
Journal:  Hepatology       Date:  2015-07-30       Impact factor: 17.425

3.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

Authors:  S Qian; L Lu; F Fu; Y Li; W Li; T E Starzl; J J Fung; A W Thomson
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

4.  CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.

Authors:  Hyo Jin Park; Dahye Byun; An Hi Lee; Ju Hyun Kim; Young Larn Ban; Masatake Araki; Kimi Araki; Ken-Ichi Yamamura; Inho Kim; Seong Hoe Park; Kyeong Cheon Jung
Journal:  Mol Cells       Date:  2012-02-15       Impact factor: 5.034

Review 5.  Synergies of Extracellular Vesicles and Microchimerism in Promoting Immunotolerance During Pregnancy.

Authors:  José M Murrieta-Coxca; Paulina Fuentes-Zacarias; Stephanie Ospina-Prieto; Udo R Markert; Diana M Morales-Prieto
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

6.  Split immunological tolerance to trophoblast.

Authors:  Amanda de Mestre; Leela Noronha; Bettina Wagner; Douglas F Antczak
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

7.  Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

Authors:  T G Markees; N E Phillips; E J Gordon; R J Noelle; L D Shultz; J P Mordes; D L Greiner; A A Rossini
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.

Authors:  R M Gorczynski; Z Chen; H Zeng; L Gorczynski; E Terzioglu
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

9.  A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.

Authors:  D Brändle; F Brasseur; P Weynants; T Boon; B Van den Eynde
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.